Anderson B M, Jackson F, Moxley M A, Longmore W J
E. A. Doisy Department of Biochemistry and Molecular Biology, St. Louis University School of Medicine, Missouri 63104.
Exp Lung Res. 1992 Mar-Apr;18(2):191-204. doi: 10.3109/01902149209031680.
Subcutaneous injection of N-nitroso-N-methylurethane (NNNMU) produces an acute lung injury mimicking the adult respiratory distress syndrome. NNNMU-injured rats treated with intratracheal Survanta, 100 mg phospholipid/kg body weight, air, or normal saline were observed for 24 h. Twenty-four hours after treatment survival among Survanta-treated rats was significantly greater than for air- and saline-treated rats (9/15 vs. 2/15 and 3/15, respectively). The alveolar-to-arterial O2 gradient was lower in Survanta-treated than in either air- or saline-treated rats during the 24-h period. Analysis of bronchoalveolar lavage fluid revealed a higher phospholipid: protein ratio (1.73 +/- 0.31 Survanta-treated, 0.20 +/- 0.05 air control, and 0.41 +/- 0.17 saline control) and a more normal phospholipid composition among treated than control rats. Minimum dynamic surface tension was significantly lower among treated rats (10.9 +/- 2.9 dyn/cm) than air and saline control rats (36.0 +/- 0.6 and 35.8 +/- 1.0 dyn/com, respectively). In vitro mixing of surfactant with pulmonary edema proteins significantly raised the minimum surface tension of surfactant from a group of Survanta-treated, NNNMU-injured rats (8.7 +/- 3.5 dyn/cm before and 32.0 +/- 0.5 dyn/cm after mixing). Intratracheal Survanta shows a beneficial effect on physiologic parameters and biochemical and functional characteristics of alveolar surfactant for 24 h in rats with NNNMU-induced acute lung injury.
皮下注射N-亚硝基-N-甲基脲(NNNMU)可引发一种类似于成人呼吸窘迫综合征的急性肺损伤。对经气管内给予舒润坦(Survanta,100mg磷脂/千克体重)、空气或生理盐水治疗的NNNMU损伤大鼠进行24小时观察。治疗24小时后,接受舒润坦治疗的大鼠存活率显著高于接受空气和生理盐水治疗的大鼠(分别为9/15 vs. 2/15和3/15)。在24小时观察期内,接受舒润坦治疗的大鼠的肺泡-动脉血氧梯度低于接受空气或生理盐水治疗的大鼠。支气管肺泡灌洗液分析显示,与对照组大鼠相比,治疗组大鼠的磷脂:蛋白比值更高(舒润坦治疗组为1.73±0.31,空气对照组为0.20±0.05,生理盐水对照组为0.41±0.17),且磷脂组成更接近正常。治疗组大鼠的最小动态表面张力(10.9±2.9dyn/cm)显著低于空气和生理盐水对照组大鼠(分别为36.0±0.6和35.8±1.0dyn/cm)。将表面活性剂与肺水肿蛋白进行体外混合,可显著提高一组经舒润坦治疗的NNNMU损伤大鼠的表面活性剂最小表面张力(混合前为8.7±3.5dyn/cm,混合后为32.0±0.5dyn/cm)。气管内给予舒润坦对NNNMU诱导的急性肺损伤大鼠的生理参数以及肺泡表面活性剂的生化和功能特性在24小时内具有有益作用。